Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shuxin Anshen
- Development stage
- Unknown
- Lead developer
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Administration
- Oral, Topical
01
Overview
Shuxin Anshen is a traditional Chinese medicine (TCM) formulation used primarily for the treatment of insomnia. It is available in several forms including ointment, paste, and decoction granules. The formulation consists of a combination of nine medicinal herbs and is based on TCM principles targeting conditions such as "yang deficiency" and "qi stagnation." Its mechanism involves modulation of sleep quality and behavior; preclinical studies suggest it may have inhibitory effects on movement behavior in animal models. Clinical trials are ongoing to evaluate its efficacy for chronic insomnia[1][2][3][4].
- Brand names
- Shuxin AnshenShuxin Anshen OintmentShuxin Anshen PasteShuxin Anshen Decoction Granule
- Other names
- 舒心安神膏
02
Targets
SYK (Spleen Tyrosine Kinase)
Beyond the preview
Go deeper on Shuxin Anshen.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shuxin Anshen.